Stock Track | Quidel Plummets 5% as JPMorgan Slashes Price Target

Stock Track

Nov 08

Quidel Corporation (QDEL) saw its shares plunge 5.03% during Friday's intraday trading session, following a bearish analyst report from JPMorgan. The significant drop comes as investors react to the downgraded outlook for the medical diagnostic solutions provider.

JPMorgan, a leading financial services firm, reduced its price target for QuidelOrtho from $26 to $22, representing a substantial 15.4% decrease in their valuation of the company. The firm also maintained its Underweight rating on QDEL shares, signaling continued skepticism about the stock's near-term performance potential.

The lowered price target and maintained Underweight rating suggest that JPMorgan analysts have concerns about Quidel's future prospects. This negative sentiment appears to have prompted investors to reassess their positions, leading to the sharp selloff observed in the market. As trading continues, market participants will be closely monitoring any further developments or analyst opinions that could impact Quidel's stock price trajectory.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1182813320"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1182813320\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1182813320?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-08 01:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182813320","market":"sg","top_or_hot":-1,"title":"Stock Track | Quidel Plummets 5% as JPMorgan Slashes Price Target","media":"Stock Track","content":"<p>Quidel Corporation (QDEL) saw its shares plunge 5.03% during Friday's intraday trading session, following a bearish analyst report from JPMorgan. The significant drop comes as investors react to the downgraded outlook for the medical diagnostic solutions provider.</p>\n\n<p>JPMorgan, a leading financial services firm, reduced its price target for QuidelOrtho from $26 to $22, representing a substantial 15.4% decrease in their valuation of the company. The firm also maintained its Underweight rating on QDEL shares, signaling continued skepticism about the stock's near-term performance potential.</p>\n\n<p>The lowered price target and maintained Underweight rating suggest that JPMorgan analysts have concerns about Quidel's future prospects. This negative sentiment appears to have prompted investors to reassess their positions, leading to the sharp selloff observed in the market. As trading continues, market participants will be closely monitoring any further developments or analyst opinions that could impact Quidel's stock price trajectory.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Quidel Plummets 5% as JPMorgan Slashes Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Quidel Plummets 5% as JPMorgan Slashes Price Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-08 01:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Quidel Corporation (QDEL) saw its shares plunge 5.03% during Friday's intraday trading session, following a bearish analyst report from JPMorgan. The significant drop comes as investors react to the downgraded outlook for the medical diagnostic solutions provider.</p>\n\n<p>JPMorgan, a leading financial services firm, reduced its price target for QuidelOrtho from $26 to $22, representing a substantial 15.4% decrease in their valuation of the company. The firm also maintained its Underweight rating on QDEL shares, signaling continued skepticism about the stock's near-term performance potential.</p>\n\n<p>The lowered price target and maintained Underweight rating suggest that JPMorgan analysts have concerns about Quidel's future prospects. This negative sentiment appears to have prompted investors to reassess their positions, leading to the sharp selloff observed in the market. As trading continues, market participants will be closely monitoring any further developments or analyst opinions that could impact Quidel's stock price trajectory.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QDEL","symbol_name":"窥得儿医药","start_time":0,"source_url":"","article_id":"1182813320","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182813320","pubTimestamp":1762537405,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Quidel Corporation (QDEL) saw its shares plunge 5.03% during Friday's intraday trading session, following a bearish analyst report from JPMorgan. The significant drop comes as investors react to the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"QDEL":"窥得儿医药"},"translate_title":"个股追踪|摩根大通下调目标价Quidel暴跌5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"QDEL":1},"content_text":"Quidel Corporation (QDEL) saw its shares plunge 5.03% during Friday's intraday trading session, following a bearish analyst report from JPMorgan. The significant drop comes as investors react to the downgraded outlook for the medical diagnostic solutions provider.\nJPMorgan, a leading financial services firm, reduced its price target for QuidelOrtho from $26 to $22, representing a substantial 15.4% decrease in their valuation of the company. The firm also maintained its Underweight rating on QDEL shares, signaling continued skepticism about the stock's near-term performance potential.\nThe lowered price target and maintained Underweight rating suggest that JPMorgan analysts have concerns about Quidel's future prospects. This negative sentiment appears to have prompted investors to reassess their positions, leading to the sharp selloff observed in the market. As trading continues, market participants will be closely monitoring any further developments or analyst opinions that could impact Quidel's stock price trajectory.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}